Calidi Biotherapeutics Inc - Class A (CLDI) Stock Price

0.318 ▼ -0.0126 (-3.81%)
Open: 0.327 Vol: 214.6K Day's range: 0.314 - 0.33 Mar 13, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CLDI Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.32▼ 0.32▼ 0.32▼ 0.34▼ 0.61▼
MA10 0.32▼ 0.33▼ 0.33▼ 0.52▼ 0.81▼
MA20 0.33▼ 0.34▼ 0.34▼ 0.65▼ 1.11▼
MA50 0.35▼ 0.35▼ 0.50▼ 0.87▼ 1.13▼
MA100 0.35▼ 0.57▼ 0.70▼ 1.16▼ 1.30▼
MA200 0.42▼ 0.80▼ 0.92▼ 1.34▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▼ 0.001▲ 0.009▲ -0.036▼ -0.096▼
RSI 21.920▼ 25.475▼ 22.686▼ 17.867▼ 30.623▼
STOCH 17.964▼ 5.376▼ 2.805▼ 2.633▼ 6.052▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -99.254▼ -99.674▼
CCI -201.859▼ -105.358▼ -106.609▼ -85.960     -174.275▼
Latest Filters Detected On CLDI
▼ RSI&STOCH $CLDI Oversold RSI + Stochastic Set Alert
BBANDS $CLDI Bollinger Bands Expanding Set Alert
▼ BREAK $CLDI Price Breaks 60 Days Low Set Alert
▼ BREAK $CLDI Price Breaks 30 Days Low Set Alert
▼ BREAK $CLDI Price Breaks 20 Days Low Set Alert
▼ BREAK $CLDI Price Breaks 10 Days Low Set Alert
Calidi Biotherapeutics Inc - Class A News
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach ...
Thursday, March 12, 2026 05:44 AM
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today presented on its proprietary ...
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
Monday, March 09, 2026 06:08 PM
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced the closing of its ...
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
Friday, March 06, 2026 09:07 AM
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced the pricing of its ...
CLDI historical stock data
date open high low close volume
13/03/26 0.327 0.33 0.314 0.318 214,600
12/03/26 0.3405 0.35 0.3216 0.3306 208,466
11/03/26 0.3586 0.3586 0.34 0.346 394,411
10/03/26 0.35 0.3644 0.3449 0.36 491,855
09/03/26 0.369 0.3699 0.35 0.3655 811,694
06/03/26 0.3809 0.3809 0.3416 0.3607 4,472,984
05/03/26 0.7799 0.7799 0.75 0.7697 31,337
04/03/26 0.7901 0.8229 0.7901 0.7945 23,188
03/03/26 0.7549 0.762 0.7308 0.7609 33,321
02/03/26 0.725 0.84 0.725 0.782 32,100
Quote Details
52wk Low:0.205
52wk High:7.32
Vol:214.6K
Avg Vol(3m):3.2M
1Y Chng:-43.82%
1M Chng:-68.82%
Add to Watch List
More Information
Index N/A
Market Cap. 2.37M